We demonstrated that in BC, the blocking of AnxA1 cleavage is essential to reduce the proliferation, invasion, and migration properties of MDA-MB-231 cells as it prevents N-terminal peptides of this protein which elicit signaling pathways through FPR1 activation [3,27]. The gene discussed is FPR1; the disease is breast cancer.